Related Experiment Videos
Neonatal carnitine palmitoyltransferase-2 deficiency: a case presenting with myopathy
1Nuffield Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford, U.K.
Neuromuscular Disorders : NMD
|March 1, 1995
Summary
A study found that a patient with a myopathic illness had enzymatically inactive carnitine palmitoyltransferase 2 (CPT2) protein in their skeletal muscle, despite normal protein levels. This suggests a novel cause for lipid accumulation disorders.
Area of Science:
- Biochemistry
- Cell Biology
- Genetics
Background:
- Mitochondria are crucial for cellular energy production.
- Fatty acid oxidation within mitochondria is vital for energy metabolism.
- Defects in mitochondrial fatty acid oxidation can lead to myopathic illnesses.
Observation:
- A 34-day-old infant presented with a myopathic illness and significant lipid accumulation in skeletal muscle.
- Enzymatic analysis of skeletal muscle revealed normal pyruvate dehydrogenase and citrate synthase activity.
- Malonyl-CoA-insensitive carnitine palmitoyltransferase (CPT2) activity was undetectable.
Findings:
- Despite absent CPT2 enzyme activity, quantitative immunoblotting confirmed normal CPT2 protein abundance in the patient's muscle.
- This indicates the presence of an enzymatically inactive CPT2 protein.
- The study identified a specific molecular defect in fatty acid oxidation.
Implications:
- The findings suggest a novel mechanism for CPT2 deficiency, involving a non-functional protein.
- This research aids in understanding the genetic and molecular basis of inherited metabolic disorders.
- Further investigation into the structural or post-translational modifications of CPT2 may be warranted.